Annual Shareholders Equity
-$71.67 M
-$33.27 M-86.62%
December 31, 2023
Summary
- As of March 7, 2025, ANRO annual stockholders equity is -$71.67 million, with the most recent change of -$33.27 million (-86.62%) on December 31, 2023.
- During the last 3 years, ANRO annual shareholders equity has fallen by -$59.19 million (-474.39%).
- ANRO annual shareholders equity is now -474.39% below its all-time high of -$12.48 million, reached on December 1, 2021.
Performance
ANRO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$165.05 M
-$14.72 M-8.19%
September 30, 2024
Summary
- As of March 7, 2025, ANRO quarterly stockholders equity is $165.05 million, with the most recent change of -$14.72 million (-8.19%) on September 30, 2024.
- Over the past year, ANRO quarterly shareholders equity has increased by +$236.72 million (+330.29%).
- ANRO quarterly shareholders equity is now -14.53% below its all-time high of $193.10 million, reached on March 31, 2024.
Performance
ANRO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ANRO Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -86.6% | +330.3% |
| 3 y3 years | -474.4% | - |
| 5 y5 years | -474.4% | - |
ANRO Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -474.4% | at low | -14.5% | +330.3% |
| 5 y | 5-year | -474.4% | at low | -14.5% | +330.3% |
| alltime | all time | -474.4% | at low | -14.5% | +330.3% |
Alto Neuroscience Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $165.05 M(-8.2%) |
| Jun 2024 | - | $179.78 M(-6.9%) |
| Mar 2024 | - | $193.10 M(-369.4%) |
| Dec 2023 | -$71.67 M | -$71.67 M(+17.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$61.10 M(+59.1%) |
| Dec 2022 | -$38.41 M(+207.8%) | - |
| Dec 2022 | - | -$38.41 M |
| Dec 2021 | -$12.48 M | - |
FAQ
- What is Alto Neuroscience annual stockholders equity?
- What is the all time high annual shareholders equity for Alto Neuroscience?
- What is Alto Neuroscience annual shareholders equity year-on-year change?
- What is Alto Neuroscience quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Alto Neuroscience?
- What is Alto Neuroscience quarterly shareholders equity year-on-year change?
What is Alto Neuroscience annual stockholders equity?
The current annual shareholders equity of ANRO is -$71.67 M
What is the all time high annual shareholders equity for Alto Neuroscience?
Alto Neuroscience all-time high annual stockholders equity is -$12.48 M
What is Alto Neuroscience annual shareholders equity year-on-year change?
Over the past year, ANRO annual stockholders equity has changed by -$33.27 M (-86.62%)
What is Alto Neuroscience quarterly stockholders equity?
The current quarterly shareholders equity of ANRO is $165.05 M
What is the all time high quarterly shareholders equity for Alto Neuroscience?
Alto Neuroscience all-time high quarterly stockholders equity is $193.10 M
What is Alto Neuroscience quarterly shareholders equity year-on-year change?
Over the past year, ANRO quarterly stockholders equity has changed by +$236.72 M (+330.29%)